What is Aktivolabs?
Founded in 2017, Aktivolabs is at the forefront of developing digital behavioral modification tools. Leveraging scientific methods and best practices, the company aims to enhance global health outcomes. Its flagship health application is driven by a proprietary algorithm that generates the Aktivolabs Score®, a digital biomarker designed to measure health and longevity. Aktivolabs is strategically focused on reaching corporations, insurers, and individuals across diverse cultures and languages, empowering them to lead longer, healthier lives.
How much funding has Aktivolabs raised?
Aktivolabs has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2022): $10M with participation from Govin Capital, Mitsui & Co., Seeds Capital, and Adaptive Capital Partner
Key Investors in Aktivolabs
Govin Capital
Govin Capital is a Singapore-based investment firm specializing in venture funding for startups, particularly in Digital Health and EdTech, aiming to provide smart capital and mentorship to help entrepreneurs access new market opportunities.
Mitsui & Co.
Mitsui & Co. is a global trading and investment company with a diverse portfolio, developing businesses through a worldwide network and focusing on supporting industry growth, promoting low-carbon energy, and enhancing quality of life through healthcare solutions.
Seeds Capital
Seeds Capital operates within the Electricity, Oil & Gas industry, providing capital and resources to ventures within its sector.
What's next for Aktivolabs?
The substantial enterprise-level funding Aktivolabs has garnered indicates a strong market validation and positions the company for significant scaling. This capital infusion is expected to fuel further development of its digital biomarker technology and expand its reach into new markets. The strategic investment suggests a focus on enhancing its platform's capabilities and potentially forging key partnerships to accelerate its mission of improving global health and longevity.
See full Aktivolabs company page
